WO2023072758 - COSMETIC, DERMATOLOGICAL OR COSMECEUTICAL TREATMENT, IN PARTICULAR PROPIGMENTING
National phase entry:
Publication Number
WO/2023/072758
Publication Date
04.05.2023
International Application No.
PCT/EP2022/079399
International Filing Date
21.10.2022
Title **
[English]
COSMETIC, DERMATOLOGICAL OR COSMECEUTICAL TREATMENT, IN PARTICULAR PROPIGMENTING
[French]
TRAITEMENT COSMÉTIQUE, DERMATOLOGIQUE OU COSMÉCEUTIQUE, EN PARTICULIER POUR LA PROPIGMENTATION
Applicants **
SEDERMA
Inventors
RINGENBACH, Caroline
MONDON, Philippe
Priority Data
FR2111341
26.10.2021
FR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2024 | |
| EPO | Filing, Examination, Granting | 8113 | |
| Japan | Filing, Examination, Granting | 2153 | |
| South Korea | Filing, Examination, Granting | 2071 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
19,101
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
According to the invention, at least one tyrosine derivative, in particular N-Palmitoyl-O-methyl-L-Tyrosine, is used for a cosmetic or nutraceutical treatment and/or the manufacture of a cosmetic or nutraceutical composition for improving the general condition of the skin and/or its appendages, in particular for a pro-pigmentation effect.[French]
Selon l'invention, au moins un dérivé de tyrosine, en particulier la N-palmitoyl-O-méthyl-L-tyrosine, est utilisé pour un traitement cosmétique ou nutraceutique et/ou la fabrication d'une composition cosmétique ou nutraceutique pour améliorer l'état général de la peau et/ou de ses organes auxiliaires, en particulier pour un effet propigmentant.